Gary Bloomgren - Concepedia

Concepedia

Author

Gary Bloomgren

Biogen (United States)ORCID

Also Known As

G Bloomgren, G. Bloomgren, G. L. Bloomgren, Gary Bloomgren, Gary L. Bloomgren, Joshua Safran

29

Publications

2.9K

Citations

14

H-Index

28

Concepts

All Affiliations

Biogen (United States)Eli Lilly (United States)Biogen (United Kingdom)

GB

About

Gary Bloomgren is an author at Biogen (United States) specializing in medicine, autoimmune disease, and arts.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	61
2	Arts	1	1	15
3	Public Health	1	1	26
4	Clinical Immunology	1	1	20
5	Diabetes	1	1	26

Gary Bloomgren

×

13

Publications

2.9K

Citations

13

H-Index

	Year	Citations
Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy Gary Bloomgren, Sandra Richman, Christophe Hotermans, New England Journal of Medicine	2012	1.2K
Increased Risk of Acute Pancreatitis and Biliary Disease Observed in Patients With Type 2 Diabetes Rebecca Noel, Daniel Braun, Ruth E. Patterson, Diabetes Care	2009	431
Anti–JC virus antibody levels in serum or plasma further define risk of natalizumab‐associated progressive multifocal leukoencephalopathy Tatiana Plavina, Meena Subramanyam, Gary Bloomgren, Annals of Neurology	2014	427
A cohort study of acute pancreatitis in relation to exenatide use David D. Dore, Gary Bloomgren, Madé Wenten, Diabetes Obesity and Metabolism	2011	145
Anti‐John Cunnigham virus antibody prevalence in multiple sclerosis patients: Baseline results of STRATIFY‐1 Carmen Bozic, Sandra Richman, Tatiana Plavina, Annals of Neurology	2011	141
Evaluation of pregnancy outcomes from the Tysabri® (natalizumab) pregnancy exposure registry: a global, observational, follow-up study Susan Friend, Sandra Richman, Gary Bloomgren, BMC Neurology	2016	128
Outcome and survival of asymptomatic <scp>PML</scp> in natalizumab‐treated <scp>MS</scp> patients Tuan Dong‐Si, Sandra Richman, Mike P. Wattjes, Annals of Clinical and Translational Neurology	2014	124
Predictors of survival and functional outcomes in natalizumab-associated progressive multifocal leukoencephalopathy Tuan Dong‐Si, Sarah Gheuens, Amy Gangadharan, Journal of NeuroVirology	2015	95
Relative risk of acute pancreatitis in initiators of exenatide twice daily compared with other anti‐diabetic medication: a follow‐up study Madé Wenten, J. A. Gaebler, Mohamed Hussein, Diabetic Medicine	2012	75
Evaluation of Pregnancy Outcomes from the TYSABRI® (Natalizumab) Pregnancy Exposure Registry (P02.127) Lynda M. Cristiano, Susan Friend, Carmen Bozic, Neurology	2013	26

Page 1